RAPP insider buying
Every open-market purchase of Rapport Therapeutics, Inc. (RAPP) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$22.02M
Insiders buying (12m)7
Purchases on record7
Last purchase filedOct 30, 2026
In the last 12 months, 7 insiders of Rapport Therapeutics, Inc. bought $22.02M of RAPP stock on the open market in 7 reported purchases. The most recent was filed on Oct 30, 2026: Healy James (Director) bought 969,480 shares at $21.00, worth $20.36M.
Get the next RAPP insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll RAPP insider purchases
| Filed | Insider | Value | Shares | Price | Stake | Trade | |
|---|---|---|---|---|---|---|---|
| Oct 30 | Healy JamesDirector | $20.36M | 969,480 | $21.00 | new | Oct 28 | SEC |
| Oct 23 | Sanchez RamiroDirector | $98.48K | 3,600 | $27.35 | new | Oct 23 | SEC |
| Oct 22 | Silva Paul MDirector | $99.64K | 3,680 | $27.07 | new | Oct 22 | SEC |
| Oct 22 | Young Wendy B.Director | $99.99K | 3,789 | $26.39 | +40% | Oct 22 | SEC |
| Oct 22 | Paul Steven MDirector | $974.28K | 35,714 | $27.28 | +86% | Oct 22 | SEC |
| Oct 22 | Maraganore JohnDirector | $248.89K | 9,411 | $26.45 | new | Oct 22 | SEC |
| Oct 21 | Ignelzi Troy A.Chief Financial Officer | $143.55K | 5,500 | $26.10 | +55% | Oct 21 | SEC |